Cambridge Major Laboratories, Inc. (CML) is a leading global chemistry outsourcing partner to the pharmaceutical and biotechnology industries. CML produces pharmaceutical intermediates and active pharmaceutical ingredients, from early preclinical development to commercial manufacturing. In October 2013, CML announced a merger with AAIPharma Services Corp, a leading provider of pharmaceutical analytical testing, product development and manufacturing services worldwide, to form a premier global supplier of integrated chemistry, manufacturing and control services.
We purchased Cambridge Major Laboratories from the widow of the company’s founder. She had been running the business for a few years following her husband’s death and wanted to retire. We partnered with the company’s Chief Chemist to buy the company. He stepped into the role of President and quickly grew Cambridge Major into a major force in the world of small scale pharmaceutical ingredients.